Home
Sign In
About
Curriculum
Activity Information
Target Audience
Learning Objectives
Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
Course materials have been developed for use outside of the United States.
|
 |
|
|
|
|
|
|
Update on Imaging: Detection of Iron in Liver and Heart
With the availability of new imaging techniques for measuring iron in the liver and heart, physicians now have the means to accurately assess their patients at risk for iron overload and to take the steps necessary to treat excess iron and prevent associated morbidity and mortality. In this webcast, Dr. St. Pierre discusses the measurement of liver iron concentration (LIC) and its impact on iron-induced complications and long-term prognosis, the relationship between LIC and cardiac iron, and noninvasive techniques, including biomagnetic liver susceptometry (SQUID) and magnetic resonance imaging (MRI), for measuring liver and cardiac iron, and presents suggestions for implementing these new methods in community institutions.
|
|
Faculty
|
|
|
Tim St. Pierre, BSc, PhD
Professor
School of Physics
The University of Western Australia
Crawley, Australia
|
|
|
Target Audience
This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
|
Learning Objectives
After participating in this activity, participants should be better able to:
- Apply an understanding of the appropriate use of MRI technology to assess and monitor liver and cardiac iron stores in patients at risk of iron overload in order to determine the need for chelation therapy and/or to adjust chelation regimens.
|
Disclosure Information
Tim St. Pierre, BSc, PhD, is a consultant for and a stock shareholder in Resonance Health Ltd.
|
|
|
|
|
|
|